Dr. Sabrina Badir and her company, based in Schlieren, have developed a sensor to diagnose the risk of premature birth. She is currently fundraising and continuing the efforts to collect further clinical data.
Pregnolia was presented as one of the Best Practises in the Health Report 2020 by Corinna Mühlhausen concerning trends and developments in the healthcare industry.
Prof. Kristin Myers is one of the researchers highlighted by MIT Technology Review for their work on pregnancy related topics. In this profile, she talks about her work at Columbia University and the importance of cervical stiffness to maintain pregnancy, including the usage of the Pregnolia System in her research.
The discussion about the framework agreement definitely comes at a critical timing in the Medtech industry that is undergoing dramatic regulatory changes. Are you aware of this, Switzerland?
For more information see the interview by Dr. Sabrina Badir.
Pregnolia AG has been awarded an CHF 1.4m SME Instrument Phase 2 grant. This EU Horizon 2020 business innovation grant follows the successful Phase 1 feasibility study and will be invested towards improving the manufacturability of the Pregnolia System. It will allow Pregnolia to streamline the production of its product, increase capacity and facilitate logistics – a fundamental step in company growth.
This project has received funding from the European Union's Horizon 2020 research and innovation programme under grant agreement No 873553.
For more information read the latest interview by Dr. Sabrina Badir.
Pregnolia has been named the recipient of a SME Instrument Phase 1 grant. This EU Horizon 2020 business innovation grant provides support for close-to-market feasibility assessment activities. Pregnolia will use the funding for further studying the industrialisation and production scalability of the Pregnolia System.
This project has received funding from the European Union's Horizon 2020 research and innovation programme under grant agreement No 835715.
Pregnolia was awarded the Innosuisse Certificate. The Certificate is given by the Innosuisse Innovation Council to startups that are ready for sustainable growth. Pregnolia was one of the seven companies to receive Innosuisse Certificate – former CTI Startup Label – in 2018.
Medtech as a research field has become more important at ETH. The biomechanics engineer Dr. Sabrina Badir developed a device that might support the risk assessment of a premature birth.
Dr. Reihl and Dr. Kohler were elected to the Board of Directors. Both have extensive experience in Medtech and Health Management.
The ETH-Spin-off Pregnolia has developed a small device to enable gynecologists to measure the cervical stiffness quantitatively.
Dr. Sabrina Badir and her life-changing invention have been featured in ZEIT ONLINE. The Pregnolia System provides more data on the consistency of the cervix than conventional methods.
The biomechanics Dr. Sabrina Badir wants to bring a device to the market that improves risk assessment for preterm birth. That this needs more than the courage for risk, will be discussed during the interview «Focus».
The probe measures the stiffness of the cervix: The researcher from Zurich wants to improve the assessment of preterm birth with this awardwining idea